|
Volumn 22, Issue 4, 2002, Pages 303-305
|
Halting the progression of renal disease: where we stand?
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
CARDIOVASCULAR DISEASE;
CHRONIC KIDNEY FAILURE;
COMORBIDITY;
DIABETES MELLITUS;
DISEASE COURSE;
DRUG EFFECT;
ECONOMICS;
EDITORIAL;
HUMAN;
HYPERTENSION;
JAPAN;
KIDNEY DISEASE;
PROTEINURIA;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
RISK FACTOR;
UNITED STATES;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CARDIOVASCULAR DISEASES;
COMORBIDITY;
DIABETES MELLITUS;
DISEASE PROGRESSION;
HUMANS;
HYPERTENSION;
JAPAN;
KIDNEY DISEASES;
KIDNEY FAILURE, CHRONIC;
PROTEINURIA;
RENIN-ANGIOTENSIN SYSTEM;
RISK FACTORS;
UNITED STATES;
|
EID: 0036044463
PISSN: 02116995
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (4)
|
References (0)
|